These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11546923)

  • 1. Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke.
    Merino JG; Silver B; Wong E; Demaerschalk B; Tamayo A; Hachinski V
    Stroke; 2001 Sep; 32(9):2208-9. PubMed ID: 11546923
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment--Remote evaluation of acute ischemic stroke: a reliable tool to extend tissue plasminogen activator use to community and rural stroke patients?
    Crome O; Bähr M
    Stroke; 2003 Oct; 34(10):e191-2. PubMed ID: 14500919
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis.
    Wardlaw JM; Sandercock PA; Berge E
    Stroke; 2003 Jun; 34(6):1437-42. PubMed ID: 12730560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 6. Early major ischemic changes on computed tomography should not preclude use of tissue plasminogen activator.
    Lyden P
    Stroke; 2003 Mar; 34(3):821-2. PubMed ID: 12624317
    [No Abstract]   [Full Text] [Related]  

  • 7. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M
    Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
    Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Patient Demographics, Imaging, and Beliefs Influence Tissue-Type Plasminogen Activator Use: A Survey of North American Neurologists.
    Shamy MC; Pugliese M; Meisel K; Rodriguez R; Kim AS; Stahnisch FW; Smith EE
    Stroke; 2016 Aug; 47(8):2051-7. PubMed ID: 27364532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of alteplase in the treatment of acute ischemic stroke: what nurses know?].
    Maniva SJ; de Freitas CH
    Rev Bras Enferm; 2012; 65(3):474-81. PubMed ID: 23032339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed.
    Demaerschalk BM
    Stroke; 2007 Aug; 38(8):2215-6. PubMed ID: 17641237
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient-Centered Decision Support in Acute Ischemic Stroke: Qualitative Study of Patients' and Providers' Perspectives.
    Decker C; Chhatriwalla E; Gialde E; Garavalia B; Summers D; Quinlan ME; Cheng E; Rymer M; Saver JL; Chen E; Kent DM; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2015 Oct; 8(6 Suppl 3):S109-16. PubMed ID: 26515198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data.
    Graham GD
    Stroke; 2003 Dec; 34(12):2847-50. PubMed ID: 14605319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.